An update on semaglutide for CKD in the presence of T2D
Description
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.
expert
Prof Richard MacIsaac
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne
